Cover Image

Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem

Objectives: The objective of this study was to explore the relationship between pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous-infusion (CI) meropenem and microbiological outcome in critical COVID-19 patients with documented Gram-negative superinfections. Methods: Patients r...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Sanz Codina (Author), Milo Gatti (Author), Carla Troisi (Author), Giacomo Fornaro (Author), Zeno Pasquini (Author), Filippo Trapani (Author), Andrea Zanoni (Author), Fabio Caramelli (Author), Pierluigi Viale (Author), Federico Pea (Author)
Format:	Book
Published:	MDPI AG, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration
by: Milo Gatti, et al.
Published: (2023)

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
by: Pasquale Maria Berrino, et al.
Published: (2023)

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
by: Milo Gatti, et al.
Published: (2023)

Role of a Real-Time TDM-Based Expert Clinical Pharmacological Advice Program in Optimizing the Early Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Beta-Lactams among Orthotopic Liver Transplant Recipients with Documented or Suspected Gram-Negative Infections
by: Milo Gatti, et al.
Published: (2023)

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
by: Milo Gatti, et al.
Published: (2024)

A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
by: Milo Gatti, et al.
Published: (2022)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
by: Pier Giorgio Cojutti, et al.
Published: (2021)

A Proof of Concept of the Role of TDM-Based Clinical Pharmacological Advices in Optimizing Antimicrobial Therapy on Real-Time in Different Paediatric Settings
by: Milo Gatti, et al.
Published: (2021)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
by: Pier Giorgio Cojutti, et al.
Published: (2022)

Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
by: Carla Troisi, et al.
Published: (2023)

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
by: Ute Chiriac, et al.
Published: (2023)

Pharmacokinetic/pharmacodynamic issues for optimizing treatment with beta-lactams of Gram-negative infections in critically ill orthotopic liver transplant recipients: a comprehensive review
by: Milo Gatti, et al.
Published: (2024)

Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing <i>Enterobacterales</i> Bloodstream Infections and/or Ventilator-Associated Pneumonia?
by: Milo Gatti, et al.
Published: (2023)

Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring
by: Rossella Barone, et al.
Published: (2023)

Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients
by: Abdullah Alsultan, et al.
Published: (2024)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired Pneumonia
by: Milo Gatti, et al.
Published: (2022)

An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by <i>Pseudomonas aeruginosa</i> and <i>Acinetobacter baumannii</i> in Critically Ill Adult Patients
by: Milo Gatti, et al.
Published: (2021)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
by: Milo Gatti, et al.
Published: (2021)

Fast and Simple Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Long-Term Treatment of Subacute and/or Chronic Infections
by: Rossella Barone, et al.
Published: (2023)

Fast and Sensitive Analysis of Cefiderocol in Human Plasma Microsamples by Liquid Chromatography-Isotope Dilution Tandem Mass Spectrometry for Therapeutic Drug Monitoring
by: Rossella Barone, et al.
Published: (2023)

The Superinfection of a Dermoid Cyst
by: Janelle Luk, et al.
Published: (2007)

Bacterial Superinfection of Amoebic Liver Abscess
by: Umaima Dhamrah MD, et al.
Published: (2020)

Superinfected and Ruptured Occipital Meningocele: Case Report
by: Badr Kabila MD, et al.
Published: (2023)

Improving the efficacy for meropenem therapy requires a high probability of target attainment in critically ill infants and children
by: Zeming Wang, et al.
Published: (2022)

Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfect
by: James J Bull, et al.
Published: (2024)

Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study
by: Chun Liu, et al.
Published: (2023)

Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs
by: Gatti M, et al.
Published: (2021)

Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm Study
by: Pasquale Maria Berrino, et al.
Published: (2024)

Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections
by: Nicole F. Maranchick, et al.
Published: (2023)

Superinfection with Difficult-to-Treat Pathogens Significantly Reduces the Outcome of Periprosthetic Joint Infections
by: Ali Darwich, et al.
Published: (2021)

Chronic hepatitis B and hepatitis D superinfection in patients in the brazilian Western Amazon.
by: Marcelo Siqueira de Oliveira, et al.
Published: (2015)

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing
by: Paolo Gaibani, et al.
Published: (2022)

Cytotoxicity and biocompatibility of Meropenem-loaded graphene oxide and its antibacterial effects against carbapenem-resistant Gram-negative bacteria
by: Mohammad Yousef Memar, et al.
Published: (2023)

Reliability of Kirby-Bauer disk diffusion method for detecting meropenem resistance among non-fermenting gram-negative bacilli
by: Noyal M Joseph, et al.
Published: (2011)

Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients
by: Uwe Liebchen, et al.
Published: (2021)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018
by: Paolo Gaibani, et al.
Published: (2021)

Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
by: Gavriela Voulgaridou, et al.
Published: (2023)

Severe hidradenitis suppurativa with herpes simplex virus 1 superinfection and clinical responsiveness to ixekizumab
by: Kara Reardon, MD, et al.
Published: (2021)

EFFECTIVE PREVENTION OF A BACTERIAL SUPERINFECTION WITH PHYTOPREPARATIONS IN THE EVENT OF A VIRAL RESPIRATORY INFECTION
Published: (2014)